IP Verse

Samsung Bioepis Co., Ltd. vs Regeneron Pharmaceuticals, Inc.

The detailed information for PTAB case with proceeding number IPR2023-00442 filed by Samsung Bioepis Co., Ltd. against Regeneron Pharmaceuticals, Inc. on Jan 6, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2023-00442
Filing Date: Jan 6, 2023
Petitioner: Samsung Bioepis Co., Ltd.
Respondent: Regeneron Pharmaceuticals, Inc.
Status: Final Written Decision
Respondent Application Number: 15471506
Respondent Tech Center: 1600
Respondent Patent Number: 10130681
Institution Decision Date: Jul 19, 2023
Termination Date: Jun 14, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Dismissing in Part and Denying in Part Patent Owner’s Motion to Exclude Evidence 37 C.F.R. § 42.64(c) Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a)	Jun 14, 2024	PAPER	BOARD
Other: Hearing transcript	May 20, 2024	PAPER	BOARD
Exhibit 3002	Apr 29, 2024	EXHIBIT	BOARD
Exhibit 3001	Apr 18, 2024	EXHIBIT	BOARD
Petitioner's Objections to Patent Owner's Demonstratives	Apr 17, 2024	PAPER	PETITIONER
Patent Owner's Statement of Objections to Petitioner's Demonstratives	Apr 17, 2024	PAPER	PATENT OWNER
Patent Owner's Updated Exhibit List	Apr 16, 2024	PAPER	PATENT OWNER
Ex. 2388 - Patent Owner's Demonstratives for Oral Hearing	Apr 16, 2024	EXHIBIT	PATENT OWNER
Petitioner's Updated Exhibit List	Apr 16, 2024	PAPER	PETITIONER
Ex. 1083 - Petitioner's Demonstratives for Oral Hearing	Apr 16, 2024	EXHIBIT	PETITIONER
Patent Owner's Reply to Opposition to Motion to Exclude	Apr 12, 2024	PAPER	PATENT OWNER
Petitioner's Opposition to Patent Owner's Motion to Exclude	Apr 5, 2024	PAPER	PETITIONER
Ex. 1082 - ASM Standard, PTAB-IPR2019-00369, Exhibit 1014	Apr 5, 2024	EXHIBIT	PETITIONER
ORDER Setting Oral Argument	Apr 2, 2024	PAPER	BOARD
Patent Owner's Motion to Exclude	Mar 29, 2024	PAPER	PATENT OWNER
Patent Owner's Sur-Reply	Mar 11, 2024	PAPER	PATENT OWNER
Joint Request for Oral Argument	Mar 8, 2024	PAPER	PETITIONER
Patent Owner's Amended Mandatory Notices	Feb 14, 2024	PAPER	PATENT OWNER
Patent Owner's Updated Exhibit List	Feb 9, 2024	PAPER	PATENT OWNER
Memorandum Opinion, N.D.W. Va.	Feb 9, 2024	EXHIBIT	PATENT OWNER
Patent Owner's Second Set of Objections to Petitioner's Exhibits	Jan 23, 2024	PAPER	PATENT OWNER
Ex. 1068 681 FWD	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1069 Do Tr. IPR2022-01225	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1070 Do Tr.	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1071 ANCHOR Eligibility Criteria	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1072 MARINA Eligibility Criteria	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1073 Brown Tr.	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1075 Manning Tr. IPR2022-01225	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1076 Manning Tr.	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1077 Manning Tr. IPR2021-00881	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1078 Eylea Label 2016	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1079 Regeneron 2022 Press Release	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1080 WHO 2006	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1081 Klibanov Tr.	Jan 16, 2024	EXHIBIT	PETITIONER
Ex. 1074 Brown Tr. IPR2022-01225	Jan 16, 2024	EXHIBIT	PETITIONER
Reply	Jan 16, 2024	PAPER	PETITIONER
Joint Notice of Stipulation to Modify Schedule	Jan 10, 2024	PAPER	PETITIONER
Amended Mandatory Notices	Jan 4, 2024	PAPER	PETITIONER
Amended Power of Attorney	Dec 20, 2023	PAPER	PETITIONER
ORDER Conditionally Granting Petitioner’s Motion for Admission Pro Hac Vice of Sarah M. Cork 37 C.F.R. § 42.10(c)	Dec 19, 2023	PAPER	BOARD
Joint Notice of Stipulation to Modify Schedule	Dec 14, 2023	PAPER	PETITIONER
Notice of Deposition of Alexander M. Klibanov	Dec 13, 2023	PAPER	PETITIONER
Pro Hac Vice Motion to Admit Sarah M. Cork	Dec 8, 2023	PAPER	PETITIONER
Cork Declaration ISO PHV Motion	Dec 8, 2023	EXHIBIT	PETITIONER
Notice of Deposition of Richard Manning	Dec 1, 2023	PAPER	PETITIONER
Notice of Deposition of David M. Brown	Dec 1, 2023	PAPER	PETITIONER
Notice of Deposition of Diana V. Do	Dec 1, 2023	PAPER	PETITIONER
Patent Owner's Amended Mandatory Notices	Nov 16, 2023	PAPER	PATENT OWNER
ORDER Granting Patent Owner’s Unopposed Motion for Entry of Default Protective Order 37 C.F.R. § 42.54	Nov 2, 2023	PAPER	BOARD
ORDER Conditionally Granting Petitioner’s Motions for Admission pro hac vice of Zachariah Summers and Elliot Choi 37 C.F.R. § 42.10(c)	Nov 1, 2023	PAPER	BOARD
Patent Owner's Motion to Seal	Oct 13, 2023	PAPER	PATENT OWNER
Patent Owner's Response	Oct 13, 2023	PAPER	PATENT OWNER
Ex. 2002 - Diana Do CV	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2024 - Shams US Publication 2007_0190058	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2025 - Macugen Drug Label Dec. 2004	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2032 - Regeneron Press Release Feb. 14, 2013	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2033 - Regeneron Press Release Feb. 6, 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2034 - FiercePharma 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2035 - CDER Statistical Review	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2037 - Regeneron ATU Sales Share Data - Wet AMD	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2038 - Regeneron ATU Sales Share Data - DME	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2039 - Eylea Marketing Material Nov. 2013 part 1 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2039 - Eylea Marketing Material Nov. 2013 part 2 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2040 - Regeneron Earnings Call Transcript Feb. 13, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2055 - Brown Declaration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2056 - Do Declaration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2057 - Klibanov Declaration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2058 - Manning Declaration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2059 - [CONFIDENTIAL] Manning Declaration with Attachments from IPR2021-00881	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2059 - [REDACTED] Manning Declaration with Attachments from IPR2021-00881	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2060 - Brown CV	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2061 - Klibanov CV	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2062 - Excerpts from Oxford Shorter Dictionary	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2063 - Eylea Prescribing Information	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2064 - Eylea Approval Letter	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2065 - Biochemistry 2002 5 ed	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2066 - Organic Chemistry 4th ed Chap 27 Part 1 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2066 - Organic Chemistry 4th ed Chap 27 Part 2 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2067 - Hirokawa 1988	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2068 - Prange 1998	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2069 - Mihailescu 2001	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2070 - Beek 2002	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2071 - Handgraaf 2006	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2072 - Yu 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2073 - Scott 2004	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2074 - Kleiger 2000	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2075 - Demarest 2004	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2076 - Cantu 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2077 - Biochemistry 6th ed Chap 7 Part 1 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2077 - Biochemistry 6th ed Chap 7 Part 2 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2078 - Davis-Smyth 1996	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2079 - UNIPROT - P17948 VGFR1 Human	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2080 - UNIPROT - P17948 v140 -2011-01-11	Oct 13, 2023	EXHIBIT	PATENT OWNER
EX. 2081 - Weissmann 1997	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2082 - Lu 2000	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2083 - Franklin 2011	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2084 - UNIPROT - P35968 VGFR2 Human	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2085 - UNIPROT - P35968 v127 -2011-01-11	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2086 - Bowie 1990	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2087 - US Pub 2006_0058234 A1	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2088 - lacono 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2089 - Stewart & Rosenfeld 2008	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2090 - Do 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2091 - Moroney 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2092 - US Pub 2010_0160233 A1	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2093 - Hachiya 2007	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2094 - Piques 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2095 - WO 2000_075319 A1	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2102 - Wells 2015	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2103 - [CONFIDENTIAL] REGN Research Collaboration Agreement Template	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2104 - [CONFIDENTIAL] Marmoset Pregnancy Study Email	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2109 - Rosenfeld 2006	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2110 - Genentech Press Release Dec. 30, 2005	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2112 - NCT00473330	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2113 - NCT00473382	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2114 - NCT00486018	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2115 - NCT00485836	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2116 - NCT00943072	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2117 - NCT01012973	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2118 - FDA Non-Inferiority Clinical Trials	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2119 - May 2016 Eylea Label	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2121 - Jaffe 2016	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2126 - BenEzra 2005	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2128 - Adamis Chapter 4	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2129 - Brown 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2130 - Gragoudas 2004	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2134 - Regeneron Earnings Call Tr Apr 26, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2135 - Regeneron Earnings Call Tr July 25, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2136 - Eylea Marketing Material, 2013	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2138 - [CONFIDENTIAL] Regeneron Physician ATU Wave 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2139 - Regeneron For the Treatment of Wet AMD, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2140 - [CONFIDENTIAL] Regeneron Physician ATU Wave 5	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2141 - Am. Acad. of Ophthalmol. - Anti-VEGF Treatments	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2142 - Am. Acad. of Ophthalmol. - Bevacizumab	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2143 - Am. Acad. of Ophthalmol. - Ophthalmology Subspecialists	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2144 - Am. Acad. of Ophthalmol. - Retinal Vasculitis	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2145 - Am. Acad. of Ophthalmol. - What Is Avastin	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2146 - Am. Acad. of Ophthalmol. - What Is Eylea	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2147 - Am. Acad. of Ophthalmol. - What Is Lucentis	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2148 - Am. Soc. of Retina Specialists - About Us	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2149 - Am. Soc. of Retina Specialists - Age-Related Macular Degeneration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2150 - Am. Soc. of Retina Specialists - Branch Retinal Vein Occlusion	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2151 - Am. Soc. of Retina Specialists - Central Retinal Vein Occlusion	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2152 - Am. Soc. of Retina Specialists - Diabetic Retinopathy	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2153 - Amgen - Fusion Protein	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2154 - ASHA - Calculating Medicare Fee Schedule Rates	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2155 - ASPE Issue Brief - Medicare Part B Reimbursement of Prescription Drugs	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2157 - Base Pair Biotechnologies - What is an Aptamer	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2158 - Bausch and Lomb Website - Visudyne	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2159 - Bausch and Lomb Website - Visudyne Saftey Information	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2160 - Bausch Health Companies 10-K, 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2161 - Beovu Drug Label Oct. 2019	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2162 - Beovu Drug Label June 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2163 - [CONFIDENTIAL] Regeneron Physician ATU Wave 4	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2164 - BrightFocus Foundation - AMD Facts & Figures	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2165 - Brookings - Medicare Payment for Physician-Administered (Part B) Drugs	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2166 - Calculator.net - Sample Size Calculator	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2167 - CDC - Vision Loss - A Public Health Problem	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2168 - Centers for Medicare & Medicaid Services Data - Practitioners	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement Part 1 of 3	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement Part 2 of 3	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2169 - [CONFIDENTIAL] Eylea Sample Disbursement Part 3 of 3	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2170 - [CONFIDENTIAL] US Eylea P&L	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2170 - [REDACTED] US Eylea P&L	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2171 - CloudResearch - Determining Sample Size	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2172 - CMS - 2021 ASP Drug Pricing Files	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2173 - CMS - Medicare Part B Drug Average Sales Price	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2174 - CMS - Physician Fee Schedule	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2175 - CMS Medicare Coverage Database - Billing and Coding Afilbercept	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2176 - [CONFIDENTIAL] Regeneron Q4 Performance Update	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2177 - Donahue 2007	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2178 - Donohue 2004	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2179 - Dreyfuss 2015	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2180 - Miller 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2181 - Drugs.com - Eylea FDA Approval History	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2182 - Elyasi 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2183 - Eye Care Surgery Center - Macular Degeneration	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2184 - EyeGuru - Intravitreal Injection Standard Dosing Table	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2186 - Eylea Drug Label Sept. 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2187 - Eylea Drug Label Oct. 2014	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2188 - Eylea Drug Label May 2019	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2189 - Eylea Drug Label Mar. 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2190 - Eylea Website - Dosing Flexibility for Wet AMD	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2191 - FDA Website - Drug Approval Package Macugen	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2192 - FiercePharma - Beovu, Novartis	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2193 - FiercePharma - Novartis Drug Beovu Tied to Potential Vision Loss	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2194 - FiercePharma - The top 20 drugs by worldwide sales in 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2195 - FocusVision - Survey Sample Size How Much Do I Need	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2196 - Gagnon 2008	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2197 - [CONFIDENTIAL] Eylea Physician ATU Benchmark Wave	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2198 - GEN - FDA Green-Lights Genentechs Lucentis	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2199 - Genentech Press Release June 30, 2006	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2200 - [CONFIDENTIAL] Regeneron US Eylea Historical PL	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2200 - [REDACTED] Regeneron US Eylea Historical PL	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2201 - Guha 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2202 - HCPCS Codes - HCPCS Codes	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2203 - Healio - Access to retina providers shows no geographic bias in US	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2204 - Hopkins Medicine Website - Photodynamic Therapy for AMD	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2205 - [CONFIDENTIAL] Eylea DME Market Assessment	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2206 - IQVIA 10-K 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2207 - IQVIA - Available IQVIA Data	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2208 - [CONFIDENTIAL] Eylea ATU Wave 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2209 - KFF - A Snapshot of Sources	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2210 - KFF - Medicare Advantage in 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2211 - Ling 2002	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2212 - Lucentis Drug Label 2006	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2213 - Lucentis Drug Label June 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2214 - Lucentis Drug Label Aug. 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2215 - Lucentis Drug Label Apr. 2017	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2216 - Lucentis Drug Label Mar. 2018	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2218 - [CONFIDENTIAL] Eylea Components of Reimbursement	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2218 - [REDACTED] Eylea Components of Reimbursement	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2219 - Mankiw Chapter 1	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2220 - Manning 2015	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2221 - Mayo Clinic - Wet macular degeneration - Diagnosis and treatment	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2222 - Mayo Clinic - Wet macular degeneration - Symptoms and Causes	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2223 - Medicare Interactive - Medicare Part B Covered Services	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2224 - Medicare Interactive - The parts of Medicare (A, B, C, D)	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2225 - Medicare.gov - Macular Degeneration Coverage	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2226 - Medicare.gov - Medicare Advantage Plans	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2227 - Medicare.gov - When does Medicare coverage start	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2228 - MedlinePlus Medical Encyclopedia - Laser photocoagulation	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2229 - [CONFIDENTIAL] Regeneron WAC Pricing	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2230 - Novartis - Annual Report, 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2231 - Novartis Press Release Oct. 8, 2019	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2232 - Novartis Press Release June 11, 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2233 - Oct 2012 ASP Pricing File revised 060513	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2234 - Oct 2013 ASP Pricing File updated 060614	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2235 - Oct 2015 ASP Pricing File - updated 120915	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2236 - Oct 2016 ASP Pricing File updated 082817	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2237 - Oct 2017 ASP Pricing File 083017	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2238 - Oct 2018 ASP Pricing File updated 052919	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2239 - Oct 2019 ASP Pricing File 052920	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2240 - Oct 2014 ASP Pricing File - revised 090115	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2241 - Oct 2020 ASP Pricing File updated 090121	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2242 - Oct 2021 ASP Pricing File updated 011022	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2243 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2016	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2244 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2015	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2245 - Pindyck Chapter 3	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2246 - Regeneron - About Us	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2247 - Regeneron Press Release July 29, 2014	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2248 - Regeneron Press Release Oct. 6, 2014	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2249 - Regeneron Press Release May 13, 2019	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2250 - [CONFIDENTIAL] ASRS Prefernces & Trends Survey 2014	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2251 - Regeneron - History	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2252 - Regeneron Press Release Sept. 21, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2253 - Regeneron - Research Areas	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2254 - Regeneron Form 10-K for 2020 Part 1 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2254 - Regeneron Form 10-K for 2020 Part 2 of 2	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2255 - Retinal Physician - Revisiting an Early Treatment for Wet AMD	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2256 - Roche 10-K, 2020	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2257 - Roche Press Release Aug. 13, 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2258 - Roche Press Release Apr. 18, 2017	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2259 - [CONFIDENTIAL] ASRS Preferences & Trends Survey 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2260 - Schweitzer Chapter 4	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2261 - ScienceDaily - FDA Approves First Angiogenesis Inhibitor	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2262 - Sivaprasad 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2263 - [CONFIDENTIAL] Eylea Sales Summary	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2264 - Verywell Health - Macular Degeneration Timeline	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2265 - Vestrum Health - Explore what we can do for you	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2266 - Vestrum Health - Pharmaceutical companies	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2267 - Visudyne Drug Label Apr 2016	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2268 - Weidner 2021	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2269 - WHO - Blindness and vision impairment	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2270 - Yahoo Finance - Beovu Now Publicly Reimbursed	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2271 - Yorston 2014	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2272 - [CONFIDENTIAL] Eylea Q2 2021 Performance	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2273 - [CONFIDENTIAL] Vestrum Anti-VEGF Category Sales Shares	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2274 - [CONFIDENTIAL] Eylea Wet AMD Line of Therapy Insights	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2275 - [CONFIDENTIAL] Vestrum Anti-VEGF Market Share Adjustment	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2276 - [CONFIDENTIAL] Eylea Q2 2020 Performance	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2277 - [CONFIDENTIAL] Regeneron Marketing Planning Process	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2278 - [CONFIDENTIAL] Regeneron Wave 1 2021 Performance Update	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2279 - Regeneron ATU Sales Share Data - All Indications	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2282 - Regeneron ATU Sales Share Data - CRVO	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2283 - Regeneron ATU Sales Share Data - BRVO	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2284 - Regeneron ATU Sales Share Data - DR without DME	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2285 - [CONFIDENTIAL] Eylea Gross & Net Sales P&L	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2285 - [REDACTED] Eylea Gross & Net Sales P&L	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2289 - Retinal Physician Symposium	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2290 - Lucentis Label 2006	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2293 - Margolis 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2295 - Spaide 2007	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2296 - Brown 2011	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2297 - Heier 2011	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2298 - [CONFIDENTIAL] Research Agreement	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2299 - [CONFIDENTIAL] VGFT-OD-0605 Protocol Signature Page	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2300 - Eylea P I	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2301 - Regeneron Corrected Press Release Nov. 18, 2011	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2302 - Eylea Approval Letter	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2303 - Bhisitkul & Stewart 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2304 - FDA 22 Case Studies	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2305 - NCT02247531	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2306 - NCT02247479	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2307 - NCT03577899	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2308 - NCT03630952	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2309 - NCT01944839	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2310 - NCT01940900	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2311 - Mathis 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2312 - Cousins 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2313 - Helzner 2007	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2314 - FDA Guidance -Expedited Programs	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2315 - NCT01486771	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2316 - Gallemore 2008	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2317 - Kanghong Press Release - Translation	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2318 - Kanghong Press Release - Chinese	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2319 - Thomas 2013	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2320 - Ohr 2012	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2321 - FDA Approves Eylea for Wet AMD	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2332 - Ophthotech Press Release, Dec. 12, 2016	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2333 - Genentech Press Release, Nov. 9, 2017	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2334 - Ciulla & Rosenfeld 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2360 - Order On Claim Construction, DN 427, N.D.W. Va.	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2361 - Regeneron Press Release, May 8, 2008	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2362 - Heier 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2363 - Ni 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2364 - Fung 2007	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2365 - Lalwani 2009	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2366 - Retina Society Meeting Presentation	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2368 - Toy MACTEL paper	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2369 - HHS - Approval of Research with Conditions, OHRP Guidance (2010)	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2370 - pegaptanib VISION	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2371 - Getz 2011	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2372 - Buyse 2016	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2375 - Am. Acad. of Ophthalmol. - What Is Macular Telangiectasia	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2376 - Basic and Clinical Science Course, Sec. 9, Ch. 9	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2377 - Mueller 2008	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2378 - Pathobiology of Ocular Disease, Ch. 3	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2379 - Caspi 2010	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2380 - Bodaghi 2001	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2381 - Mayo Clinic - Stye (sty) - Symptoms & causes	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2382 - Bos Childrens Hosp - Orbital Cellulitis (Periorbital Cellulitis)	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2383 - Fundamentals of Clinical Trials, Ch. 4	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2384 - Deposition of Edward Chaum	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2385 - FDA.gov - Step 3 - Clinical Research	Oct 13, 2023	EXHIBIT	PATENT OWNER
Ex. 2386 - Excerpt from Webster's Dictionary	Oct 13, 2023	EXHIBIT	PATENT OWNER
Patent Owner's Unopposed Motion for Entry of Default Protective Order	Oct 6, 2023	PAPER	PATENT OWNER
Pro Hac Vice Motion to Admit Zach Summers	Sep 26, 2023	PAPER	PETITIONER
Summers Declaration ISO PHV Motion	Sep 26, 2023	EXHIBIT	PETITIONER
Pro Hac Vice Motion to Admit Elliot Choi	Sep 26, 2023	PAPER	PETITIONER
Choi Declaration ISO PHV Motion	Sep 26, 2023	EXHIBIT	PETITIONER
Amended Notice of Deposition of Edward Chaum	Sep 21, 2023	PAPER	PATENT OWNER
ORDER Granting Patent Owners Motions for Admission Pro Hac Vice of Abigail Struthers, Jeremy Cobb, Victoria Reines, and Matthew Wilk 37 C.F.R. § 42.10 c	Aug 17, 2023	PAPER	BOARD
Patent Owner's Notice of Deposition of Edward Chaum	Aug 15, 2023	PAPER	PATENT OWNER
Patent Owner's Amended Mandatory Notices	Aug 3, 2023	PAPER	PATENT OWNER
Patent Owner's Objections to Petitioner's Exhibits	Aug 2, 2023	PAPER	PATENT OWNER
Patent Owner's Updated Exhibit List	Jul 28, 2023	PAPER	PATENT OWNER
Pro Hac Vice Motion to Admit Abigail Struthers	Jul 28, 2023	PAPER	PATENT OWNER
Ex. 2050 - Declaration of Abigail Struthers	Jul 28, 2023	EXHIBIT	PATENT OWNER
Pro Hac Vice Motion to Admit Jeremy Cobb	Jul 28, 2023	PAPER	PATENT OWNER
Ex. 2052 - Declaration of Jeremy Cobb	Jul 28, 2023	EXHIBIT	PATENT OWNER
Pro Hac Vice Motion to Admit Victoria Reines	Jul 28, 2023	PAPER	PATENT OWNER
Ex. 2053 - Declaration of Victoria Reines	Jul 28, 2023	EXHIBIT	PATENT OWNER
Pro Hac Vice Motion to Admit Matthew Wilk	Jul 28, 2023	PAPER	PATENT OWNER
Ex. 2054 - Declaration of Matthew Wilk	Jul 28, 2023	EXHIBIT	PATENT OWNER
Granting Institution of Inter Partes Review 35 U.S.C. 314	Jul 19, 2023	PAPER	BOARD
SCHEDULING ORDER	Jul 19, 2023	PAPER	BOARD
Patent Owner's Sur-Reply to Petitioner's Reply to POPR	May 24, 2023	PAPER	PATENT OWNER
Petitioner's Reply to POPR	May 17, 2023	PAPER	PETITIONER
Ex 1064 Board's May 11, 2023 Email	May 17, 2023	EXHIBIT	PETITIONER
Preliminary Response of Patent Owner	Apr 25, 2023	PAPER	PATENT OWNER
Ex. 2021 - Albini January Deposition Transcript	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2106 - Macugen Approval Letter	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2107 - 2004 Macugen Label	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2108 - NCT00473330	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2111 - Genentech Press Release June 30, 2006	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2120 - Am Acad Opthalmolgy - Sect 9, Chap 6	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2131 - Regillo 2008	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2132 - Levine 2009	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2156 - Avastin Drug Label 2004	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2185 - Eylea Drug Label Nov. 2011	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2286 - Abraham 2010	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2287 - Barbazetto 2010	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2288 - Cruz 2006	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2291 - Schmidt-Erfuth 2011	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2292 - Boyer 2009	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2294 - Park 2012	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2345 - NCT00056836	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2346 - NCT00061594	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2347 - Lucentis MR	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2348 - NCT00090623	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2349 - Mitchell	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2351 - Christensen	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2352 - NCT00685854	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2353 - CATT	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2354 - Bhatt	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2355 - Eylea MR	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2356 - NCT-377	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2357 - Motion for Joinder, IPR2023-00566	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2358 - N C T-795	Apr 25, 2023	EXHIBIT	PATENT OWNER
Ex. 2359 - Biotechnology Fundamentals 3d Ed, Ch 11	Apr 25, 2023	EXHIBIT	PATENT OWNER
Notice : Power of Attorney	Feb 14, 2023	PAPER	PETITIONER
Notice : Power of Attorney	Jan 30, 2023	PAPER	PATENT OWNER
Notice : Mandatory Notice	Jan 30, 2023	PAPER	PATENT OWNER
Notice: Notice filing date accorded	Jan 25, 2023	PAPER	BOARD
Ex. 1001 - US10130681	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1003 - Chaum CV	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1004 - 338 Patent FWD	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1005 - NIH AMD	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1006 - Dixon	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1007 - Regeneron September 14, 2009 Press Release	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1008 - Halpern 2006	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1009 - Holash	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1010 - Rudge 2005	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1011 Gomez Manzano	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1012 - Adis	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1013 - US7531173	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1014 - Rudge 2007	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1015 - Li	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1016 - Heier 2012	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1017 - Brown 2009	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1018 - Martin	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1019 - Heier 2011	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1020 - Chakravarthy	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1021 - Rosenfeld	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1022 - Heimann	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1023 - Uveitis Fact Sheet	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1024 - Conjunctivitis Overview	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1025 - 681 patent PH	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1026 - Lucentis Label 2006	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1027 - 338 patent PH	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1028 - 338 patent	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1029 - 069 patent	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1031 - CATT Study	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1033 - MACTEL Study Wayback Machine	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1034 - PIER Study	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1035 - NCT00593450	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1036 - 758 patent	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1037 - Dix	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1038 - Brown 2005	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1039 - AAO What is a Slit Lamp	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1040 - Jaffe	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1041 - Safe Intravitreal Injection Technique	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1043 - Using the Wayback Machine	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1044 - NCT00685854 and Glossary	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1046 - 069 patent FWD	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1047 - 069 patent Institution Decision	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1048 - Dixon Published Date	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1049 - ClinicalTrials.gov Background	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1050 - About the Results Database	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1051 - How to Read a Study Record	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1052 - AJO PIER Study Published Date	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1053 - History of Changes (NCT00090623)	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1054 - Del Piore Decl. filed in IPR2021-00881	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1055 - Oral Hearing Transcript (IPR2021-00880, 881)	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1056 - 758 patent PH 12/22/2011 PTE	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1057 - Regeneron 10-Q (Sept. 30, 2009)	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1058 - 681 patent IPR Petition by Mylan (IPR2022-01225)	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1059 - Jager	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1060 - Regeneron Complaint	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1062 - Eylea Label	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1063 - NHS Uveitis Overview	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1030 - Jt. CC Chart	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1042 - Regeneron April 28, 2008 Press Release	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1045 - History of Changes (NCT00685854)	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1061 - Eylea Purple Book Patent List	Jan 6, 2023	EXHIBIT	PETITIONER
Ex. 1032 - NCT00685854 (May 24, 2008)	Jan 6, 2023	EXHIBIT	PETITIONER
Notice : Power of Attorney	Jan 6, 2023	PAPER	PETITIONER
Petition	Jan 6, 2023	PAPER	PETITIONER
Ex. 1002 - Chaum Decl.	Jan 6, 2023	EXHIBIT	PETITIONER